Favorable Biochemical Freedom From Recurrence With Stereotactic Body Radiation Therapy for Intermediate and High-Risk Prostate Cancer: A Single Institutional Experience With Long-T...

by Anthony Ricco, Gabrielle Barbera, Rachelle Lanciano, Rachelle Lanciano, Jing Feng, Alexandra Hanlon, Alicia Lozano, Michael Good, Stephen Arrigo, Stephen Arrigo, John Lamond, John Lamond, Jun Yang
Published 2020-09-01

The Comparison of Stereotactic Body Radiation Therapy (SBRT) andIntensity Modulated Radiation Therapy (IMRT) for prostate cancer byNCCN risk groups

by Anthony Ricco, Genevieve Manahan, Genevieve Manahan, Rachelle Lanciano, Rachelle Lanciano, Alexandra Hanlon, Jun Yang, Jun Yang, Stephen Arrigo, John Lamond, John Lamond, Jing Feng, Michael Mooreville, Bruce Garber, Luther Brady, Luther Brady
Published 2016-08-01

Single Institutional Experience of Stereotactic Radiosurgery Alone for First Brain Metastatic Event and Salvage of Second Brain Metastatic Event in a Community Setting with Review...

by Shaharyar Ahmad, Anthony Ricco, Royce Brown, Alexandra Hanlon, Jun Yang, Jun Yang, Jing Feng, Michael Stanley, Richard Buonocore, Aubrey Okpaku, Steven Arrigo, John Lamond, John Lamond, Luther Brady, Luther Brady, Rachelle Lanciano, Rachelle Lanciano
Published 2017-03-01

Survival and control prognosticators of recurrent gynecological malignancies of the pelvis and para-aortic region treated with stereotactic body radiation therapy (SBRT)

by Shaakir Hasan, Anthony Ricco, Kaylette Jenkins, Rachelle Lanciano, Alexandra Hanlon, John Lamond, Jun Yang, Jing Feng, Michael Good, Joel Noumoff, Luther Brady
Published 2016-11-01

Repeat Thoracic Stereotactic Body Radiation Therapy (SBRT) for Nonsmall Cell Lung Cancer: Long-Term Outcomes, Toxicity, and Dosimetric Considerations

by Anthony Ricco, MD, Sara Barlow, BS, Jing Feng, MS, Janson Jacob, MD, Alicia Lozano, MS, Alexandra Hanlon, PhD, Stephen Arrigo, MD, Olusola Obayomi-Davies, MD, John Lamond, MD, Jun Yang, PhD, Rachelle Lanciano, MD
Published 2020-09-01